Context Therapeutics Inc. (29) | Development Agreements (3)
Recent Contracts
-
Amendment No. 2 to Process Development Agreement, dated June 3, 2021, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
(Filed With SEC on June 16, 2021)
-
Process Development Agreement, dated March 6, 2020, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
(Filed With SEC on May 27, 2021)
-
Amendment No. 1 to Process Development Agreement, dated April 21, 2021, between Context Therapeutics LLC and Tyligand Bioscience (Shanghai) Limited
(Filed With SEC on May 27, 2021)
